It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Following primary SARS-CoV-2 vaccination, whether boosters or breakthrough infections provide greater protection against SARS-CoV-2 infection is incompletely understood. Here we investigated SARS-CoV-2 antibody correlates of protection against new Omicron BA.4/5 (re-)infections and anti-spike IgG antibody trajectories after a third/booster vaccination or breakthrough infection following second vaccination in 154,149 adults ≥18 y from the United Kingdom general population. Higher antibody levels were associated with increased protection against Omicron BA.4/5 infection and breakthrough infections were associated with higher levels of protection at any given antibody level than boosters. Breakthrough infections generated similar antibody levels to boosters, and the subsequent antibody declines were slightly slower than after boosters. Together our findings show breakthrough infection provides longer-lasting protection against further infections than booster vaccinations. Our findings, considered alongside the risks of severe infection and long-term consequences of infection, have important implications for vaccine policy.
The duration and strength of protection against SARS-CoV-2 infection resulting from a booster vaccine dose or breakthrough infection are not well understood. This study uses data from the UK COVID-19 Infection Survey to investigate correlates of protection against Omicron BA.4/5 infection and assess antibody responses to booster vaccination and breakthrough infections.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details





1 University of Oxford, Nuffield Department of Medicine, Oxford, UK (GRID:grid.4991.5) (ISNI:0000 0004 1936 8948); University of Oxford, Big Data Institute, Nuffield Department of Population Health, Oxford, UK (GRID:grid.4991.5) (ISNI:0000 0004 1936 8948)
2 University of Oxford, Nuffield Department of Medicine, Oxford, UK (GRID:grid.4991.5) (ISNI:0000 0004 1936 8948); The Francis Crick Institute, London, UK (GRID:grid.451388.3) (ISNI:0000 0004 1795 1830); University College London, Division of infection and immunity, London, UK (GRID:grid.83440.3b) (ISNI:0000000121901201)
3 University of Oxford, Nuffield Department of Medicine, Oxford, UK (GRID:grid.4991.5) (ISNI:0000 0004 1936 8948); Oxford University Hospitals NHS Foundation Trust, John Radcliffe Hospital, Department of Infectious Diseases and Microbiology, Oxford, UK (GRID:grid.8348.7) (ISNI:0000 0001 2306 7492); The National Institute for Health Research Health Protection Research Unit in Healthcare Associated Infections and Antimicrobial Resistance at the University of Oxford, Oxford, UK (GRID:grid.4991.5) (ISNI:0000 0004 1936 8948); The National Institute for Health Research Oxford Biomedical Research Centre, University of Oxford, Oxford, UK (GRID:grid.454382.c) (ISNI:0000 0004 7871 7212)
4 University of Exeter, European Centre for Environment and Human Health, Truro, UK (GRID:grid.8391.3) (ISNI:0000 0004 1936 8024)
5 Office for National Statistics, Newport, UK (GRID:grid.426100.1) (ISNI:0000 0001 2157 6840)
6 University of Oxford, Office of the Regius Professor of Medicine, Oxford, UK (GRID:grid.4991.5) (ISNI:0000 0004 1936 8948)
7 Wellcome Trust, London, UK (GRID:grid.52788.30) (ISNI:0000 0004 0427 7672)
8 University of Oxford, Nuffield Department of Medicine, Oxford, UK (GRID:grid.4991.5) (ISNI:0000 0004 1936 8948); Oxford University Hospitals NHS Foundation Trust, John Radcliffe Hospital, Department of Infectious Diseases and Microbiology, Oxford, UK (GRID:grid.8348.7) (ISNI:0000 0001 2306 7492)
9 University of Oxford, Nuffield Department of Medicine, Oxford, UK (GRID:grid.4991.5) (ISNI:0000 0004 1936 8948); University of Oxford, Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, Oxford, UK (GRID:grid.4991.5) (ISNI:0000 0004 1936 8948)
10 University of Oxford, Nuffield Department of Medicine, Oxford, UK (GRID:grid.4991.5) (ISNI:0000 0004 1936 8948)
11 University of Oxford, Nuffield Department of Medicine, Oxford, UK (GRID:grid.4991.5) (ISNI:0000 0004 1936 8948); University of Oxford, Big Data Institute, Nuffield Department of Population Health, Oxford, UK (GRID:grid.4991.5) (ISNI:0000 0004 1936 8948); The National Institute for Health Research Health Protection Research Unit in Healthcare Associated Infections and Antimicrobial Resistance at the University of Oxford, Oxford, UK (GRID:grid.4991.5) (ISNI:0000 0004 1936 8948); MRC Clinical Trials Unit at UCL, UCL, London, UK (GRID:grid.83440.3b) (ISNI:0000000121901201)
12 The National Institute for Health Research Health Protection Research Unit in Healthcare Associated Infections and Antimicrobial Resistance at the University of Oxford, Oxford, UK (GRID:grid.4991.5) (ISNI:0000 0004 1936 8948); University of Oxford, Health Economics Research Centre, Nuffield Department of Population Health, Oxford, UK (GRID:grid.4991.5) (ISNI:0000 0004 1936 8948)
13 University of Oxford, Big Data Institute, Nuffield Department of Population Health, Oxford, UK (GRID:grid.4991.5) (ISNI:0000 0004 1936 8948); Oxford University Hospitals NHS Foundation Trust, John Radcliffe Hospital, Department of Infectious Diseases and Microbiology, Oxford, UK (GRID:grid.8348.7) (ISNI:0000 0001 2306 7492); The National Institute for Health Research Health Protection Research Unit in Healthcare Associated Infections and Antimicrobial Resistance at the University of Oxford, Oxford, UK (GRID:grid.4991.5) (ISNI:0000 0004 1936 8948); The National Institute for Health Research Oxford Biomedical Research Centre, University of Oxford, Oxford, UK (GRID:grid.454382.c) (ISNI:0000 0004 7871 7212)
14 University of Oxford, Big Data Institute, Nuffield Department of Population Health, Oxford, UK (GRID:grid.4991.5) (ISNI:0000 0004 1936 8948)
15 Oxford University Hospitals NHS Foundation Trust, Oxford, UK (GRID:grid.410556.3) (ISNI:0000 0001 0440 1440)
16 University of Manchester, Manchester, UK (GRID:grid.5379.8) (ISNI:0000000121662407)
17 Public Health England, Health Improvement Directorate, London, UK (GRID:grid.271308.f) (ISNI:0000 0004 5909 016X)
18 IQVIA, London, UK (GRID:grid.482783.2)
19 National Biocentre, Milton Keynes, UK (GRID:grid.482783.2)
20 Glasgow Lighthouse Laboratory, London, UK (GRID:grid.482783.2)
21 Department of Health and Social Care, London, UK (GRID:grid.57981.32)
22 Welsh Government, Cardiff, UK (GRID:grid.422594.c) (ISNI:0000 0004 1787 8223)
23 Scottish Government, Edinburgh, UK (GRID:grid.421126.2) (ISNI:0000 0001 0698 0044)
24 Public Health Scotland, Edinburgh, UK (GRID:grid.508718.3)